After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Ultragenyx Pharmaceutical Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Ultragenyx Pharmaceutical Inc is $3.73B. A total of 0.68 million shares were traded on the day, compared to an average of 875.13K shares.
In the most recent transaction, Horn Howard sold 1,785 shares of RARE for 40.40 per share on Mar 06 ’25. After the transaction, the Chief Financial Officer now owns 106,169 company shares. In a previous transaction on Mar 03 ’25, Kassberg Thomas Richard sold 6,028 shares at 42.10 per share. RARE shares that CBO & EVP owns now total 265,238.
Among the insiders who sold shares, Parschauer Karah Herdman disposed of 12,846 shares on Mar 03 ’25 at a per-share price of $42.10. This resulted in the EVP and Chief Legal Officer holding 75,287 shares of RARE after the transaction. In another insider transaction, Crombez Eric sold 8,945 shares at $42.10 per share on Mar 03 ’25. Company shares held by the EVP and Chief Medical Officer now total 71,922.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, RARE has a high of $60.37 and a low of $37.02.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. RARE’s latest balance sheet shows that the firm has $740.20M in Cash & Short Term Investments as of fiscal 2021. There were $41.97M in debt and $181.37M in liabilities at the time. Its Book Value Per Share was $2.76, while its Total Shareholder’s Equity was $922.56M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RARE is Buy with a score of 4.85.
